Mary Caffrey

Paying close attention to the area around the wound and frequent measurement made a difference.

Researchers noted that the oral therapy functions independently of insulin to carry excess blood glucose out of the system.

The results support policy positions that diabetes self-management education and support should occur at transitions in care.

The results were profound enough that researchers say it might be wise to screen patients for diabetes if their spouse is obese.

The problem caused an overdelivery of insulin in some cases. A design update in April 2017 corrected the problem but some patients still have lots of defective infusion sets.

A group that represents both community-based and virtual providers finds many issues with CMS' proposal for Medicare's Diabetes Prevention Program.

As physicians treat patients with elevated low-density lipoprotein (LDL) cholesterol more aggressively with PCSK9 inhibitors and high-efficacy statins, a test that is more accurate at lower levels is essential.

Dexcom's partnerships are giving people with diabetes technology that will be less invasive and use products that everyone else wears and uses: fitness trackers and smartphones.

The study's lead investigator said most of the focus after the World Trade Center attacks has been on mental health, but there were physical effects, too.

The "Day of Action" seeks to unite people with diabetes online and asks them to contact their representatives. Fixing the insulin pricing system in the United States will be difficult-even experts say it's very complex.

Three separate applications are pending involving the SGLT2 inhibitor.

Data presented during PAINWeek show that the rate of drug misuse among teenagers has dropped dramatically.

The study uncovered differences by race and education level in lifetime obesity status.

Penn Medicine researchers led the analysis of genome sequence information that revealed 16 previously unreported areas connected to type 2 diabetes and 1 connected to coronary heart disease, with 8 variants tied to both conditions.

Quality measurement is here to stay, but a JAMA viewpoint asks if anyone is keeping tabs on the costs of measurement.

Desmond Bell, DPM, CWS, said the patients he's seeing in his wound clinic are getting younger, suggesting that the challenge of preventing complications from peripheral artery disease will increase.

The study finds that the GLP-1 receptor agonist can slow progression of kidney disease, one of the most costly and debilitating complications of type 2 diabetes.

There are positive signs among the youngest children in states where adult obesity rates are highest, but the challenge is to continue that progress as these children get older.

The findings will likely add to the controversy over the US dietary guidelines. Lobbyists for grain interests have long been accused of having undue influence in food policy, especially over the now-discarded "food pyramid."

The merger is yet another sign that in healthcare, it's all about the data.

According to the CDC, 8.9% of children aged 2 to 5 are obese and more than 20% of youth are obese by the time they are 12 to 19 years old.

The largest study of its type sought to pinpoint when the link between weight gain in pregnancy and childhood obesity occurs.

The report finds that the same technology that physicians use to remind patients about appointments can be used to send reminders about screenings or that a payment is past due.

A Dexcom spokeswoman said there are already 20,000 Medicare patients in the pipeline with almost no advertisement of the policy change.

Two Harvard health experts take an in-depth look at who benefits from Medicaid: children and the elderly consume the vast majority of the dollars spent.

The American Diabetes Association (ADA) today offered a position statement on treating diabetes and hypertension for the first time since 2003.

Children who were obese or at risk of obesity had less activity in the brain's self-regulation centers.

More work needs to be done before this discovery can be translated into a therapeutic solution, but researchers have gained insights into why some people become infected with a pathogen and others don't.

To avoid bias, the study did use aggressive titration protocols that might be found in a real-world setting. Still, patients using CGM saw greater reductions in A1C and more time in range.

A cardiovascular outcomes trial has already shown a reduction in cardiovascular events, but not deaths.